chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blurred vision; blood sugar 611; This spontaneous case was reported by a nurse and describes the occurrence of VISION BLURRED (blurred vision) and BLOOD GLUCOSE INCREASED (blood sugar 611) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 026L2019) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus. Concomitant products included TELMISARTAN for Blood pressure, METFORMIN and BUSPIRONE HYDROCHLORIDE (BUSPAR) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (blurred vision) and BLOOD GLUCOSE INCREASED (blood sugar 611). At the time of the report, VISION BLURRED (blurred vision) and BLOOD GLUCOSE INCREASED (blood sugar 611) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  no treatment information provided.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Incredible itchy (injection site)) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Incredible itchy (injection site)). At the time of the report, VACCINATION SITE PRURITUS (Incredible itchy (injection site)) outcome was unknown. Concomitant medications include blood thinner and diabetes type 2. Patient applied Benadryl topic cream for vaccination site pruritus. Patient gave consent for Follow-up. This case was linked to MOD-2021-029897.
3/31/2021 - First dose of Covid 19 Pfizer vaccine 4/14/2021 - Revenesse Versa - under both eyes - injectable filler 4/24/2021 - I have very bad allergies to pollen/trees/grass and was outside all day doing yardwork...eyes started to bother me very badly -itchy, red, and both swelled up under both my eyes (injection site) 4/25/2021- symptoms continue.  swelling not subsided.  have been taking Benadryl since 10am.  Its now 4:30PM.   no doctors are available to report this to since its a Sunday 4/26/2021 - after doing research ive decided to cancel my second dose of Pfizer vacinne which is scheduled for 5pm 4/26/2021.  the risk is too high in my mind and im already 80percent immune.
This spontaneous report was received from a registered nurse and refers to patients of unknown age and gender. The patient's concurrent conditions and medical history, were not reported. On 11-OCT-2016, the patients was vaccinated with a dose of PNEUMOVAX 23 expiration date of 28-JUN-2016 (route, dose number, concentration, dose, anatomical place of vaccination and lot # were not provided). Nevertheless, no adverse effects were reported. Additional information has been requested.
Red rash approximately 1 1/2 inch  circle at injection site 10 days after receiving vaccine. It itched and was hot to touch. Today is fourth day of rash and it seems to be getting lighter in color and does not itch as much. I read an article about this symptom and it is reported as "Covid Arm" 8th day delayed cutaneous hypersensitivity reaction. Should go away.
given expired vaccine; No adverse event; given expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given expired vaccine), PRODUCT STORAGE ERROR (given expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 21-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 083B22A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (given expired vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (given expired vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given expired vaccine), PRODUCT STORAGE ERROR (given expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (given expired vaccine) and PRODUCT STORAGE ERROR (given expired vaccine).    No concomitant medications were reported.  A nurse reported that they had 2 patients who were given expired doses of the Moderna vaccine on 30-Nov-2022. Manufacturer expiration date was reported as 28-Nov-2022. Patient had not reported any adverse events. Vial size was reported as 5.5ml.  On 29-Nov-2022, the vial was initially stored in the refrigerator.  On 30-Nov-2022, the patient administered vaccine at 1:00 or 2:00pm.   The vial did not undergo any temperature excursions.  No treatment medications were reported.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021 at 11:18 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jan-2021 at 11:18 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 80.53 for dose administered on 07-Jan-2021 at 11:18 AM.  No concomitant medications were reported.  Batch number 025L20A underwent temperature excursion on 07-Jan-2021 with temperature 34 degrees Fahrenheit from 09:00 AM to 10:00 AM. This vial was moved to fridge on 05-Jan-2021 and beyond use date for the vial was reported as 27-Jan-2021. Product moved to clinic on 07-Jan-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
I started having extremely bad headaches on 4/14/2021 that are continuing as of 4/16/2021. I also have congestion and a runny nose that I did not have previously.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Site: Pain at Injection Site-Severe, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: pain of the arem received the injection, couldn't lift the arm well, no mobility of the affected arm
05/04/17 Increased heart rate 90-100 beats per minute. 05/10-05/16/2017 Pain to legs, hips and joints. 05/12/2017 Nodules appeared to base of skull. 05/14/2017 Began MOTRIN use. 05/16-05/17/2017 Fever and chills. Temp. not documented per report of client. 05/18/2017 "rash all over" when asked specifically stated, "arms, chest and legs." Left leg and arm numbness on and off. Client reports went to ER via ambulance. Client reported all of this effects on 05/19/2017 via phone call to the Coordinating Nurse at the Health Department. Reported she told her PCP Dr. and he instructed her to call the health department. Reports she never had vaccines as a child due to her parent's religious beliefs. Vaccines needed to attend nursing school.
When assessed, patient did not notify hospital that he had previously received a dose of Pfizer COVID vaccine. Patient stated that he wanted the COVID vaccine. On June 3rd patient received a dose of Janssen COVID vaccine. No adverse reactions noted during hospital stay.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX injection (strength, dose, route of administration, lot# and expiry date were not reported). There were no concomitant therapies reported. No adverse symptoms were reported. There was no product quality complaint (PQC) involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Labs and CT done to follow up on pancreatic cancer history. CA 19-9 (54) and CEA (4.7) are now high and it is 3 months since previous test. CT also noticed enlarged ileac lymph node when compared to CT 3 months ago (October 2020). Dr is wondering if these are related to the COVID vaccine I had 2 weeks prior to the CT and labs.
On 6/14/2022, that evening, I noticed a few sneezes but that is not out of the norm for me because I have outdoor allergies. The next morning, I had a new patient appointment at noon with a gynecologist. I took a shower that morning and realized around 10AM that I did not feel well. So I took my temperature and it was slightly elevated at just under 100 degrees. I had a few at home COVID-19 tests, so I took one and the results were positive at which point I cancelled my appointment. Throughout that day, I began to feel progressively worse. The next few days, I felt terrible and was experiencing fever, body aches, headaches, extreme fatigue, and a cough. Leading up to these events, I had been on a trip about 10 days for an out door concert. I did however, ride in a car with 3 other people. Around 2 days after we returned, one of the people that travelled in the car with me, informed me that he was having COVID-19 like symptoms but tested negative for COVID-19 and positive for type 2 Flu and to my knowledge, no one in our group tested positive with the exception of me who tested positive around 10 days after we returned. The Sunday before I tested positive, I visited a exhibit with a friend and wore a mask, but none of the other patrons were wearing masks. We also visited a restaurant and maintained our mask wearing. After testing positive, I called my doctor's office and informed them of my positive results and to ask about a Paxlovid prescription. Within an hour, he called in a prescription for Paxlovid and a Cough medicine. I began taking those the same day that I tested positive. By day 3 my fever was gone and my body aches, headaches, and cough lessened but continued in a more mild capacity for a few more days. The following Monday, 6/20/2022, I took another at home COVID-19 test. The results were still positive, but the line was much lighter. The following Wednesday 06/22/22 I tested myself again and was negative. At this point, all of my symptoms have gotten better with the exception of noticeable fatigue after any activity and a slight cough. Although on Friday, 07/01/2022, I noticed some redness, achiness, and itchiness in my eyes that felt like an allergic reaction or pink eye. I emailed my doctor to inform him that I was using artificial tears and allergy medicine. He called in a prescription for an antibiotics which has helped.
At 12:22 on Tuesday, February 9, the second day, I was awakened by violent shivering and shaking uncontrollably.  This lasted for four hours, with concomitant loss of sleep throughout the night and, when up, walking like a drunken man.  In the morning , no appetite  (managed a cereal breakfast).  Ibuprofen administered.  A pronounced feeling of weakness and lassitude throughout the morning, with slow recovery until mid-evening.  Now at February 10th, return to normal feeling and strength.
Significant adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Significant adverse reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Significant adverse reaction). At the time of the report, VACCINATION COMPLICATION (Significant adverse reaction) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
The pt experienced a rash on the torso. Cetirizine was given for the itch.
In May 1999, pt recv'd his 1st injection of Lymerix.  Within 2 days, he exp severe pain in his lt knee, leg, & buttock. Additional info has been requested.
Chest wall pain. Ibuprofen. Still persisting with pain after 4 days
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Hypotension-Severe, Systemic: Shakiness-Severe, Systemic: Weakness-Severe, Additional Details: Pt came into the pharmacy looking to get his first covid-19 vaccine.He filled out paperwork that had all "Nos" to the questions. Pharmacist gave shot at 9:24am, pt sat down in waiting area 9:25am, he felt faint and got up from the chair 9:27am, he fell into the front registers while fainting/blacking out at 9:27:34am where he fell to the ground, pharmacist ran to his assistance, he was unconcious for 24 seconds,called 911, kept patient on ground till he came to, sat back in chair till EMS arrive.
Recurring localized migraine in left temple lasting for over a week; This is a spontaneous report from a contactable healthcare professional (patient). A 24-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on the left arm on 08Jan2021 15:15 at a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications taken with two weeks included melatonin, birth control, an unspecified inhaler, and vitamins. The patient previously received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on the left arm on 20Dec2020 07:30 PM. The patient had no other vaccine in four weeks. The patient had no Covid prior to vaccination. The patient experienced recurring localized migraine in left temple lasting for over a week on 10Jan2021 21:00. Treatment for the event was unknown. The patient underwent Covid test post vaccination on 16Jan2021 with pending result. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Tingling and numbness in both arms (below the elbow to hands) & legs (below the knees to the feet). Started in right arm and progress to the other extremities within a few hours. Neurologist has seem me and is conduction further tests including an EMG. Test is being taken 4/30/21. At this time the tingling and numbness has climbed above the knee and has stayed the same in the arms.
Still nervous; fall last night; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  An 80 year-old female patient BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 27Feb2021 15:35 (Lot number: EN6200) at the age of 80 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FALL (non-serious) with onset 25Mar2021, outcome "unknown", described as "fall last night"; NERVOUSNESS (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Still nervous". The event "fall last night" was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The patient has not taken any other products. The patient had a nasty fall last night and she is still nervous about it today. She had the shot in Feb2021 but she doesn't remember the exact date. She has recently moved and doesn't have access to a lot of records. She is waiting to go today but she needs to know if we have a record of when she got the first shot. It was supposed to be three weeks but she thinks it is longer. She fell last night face first over the rug on the hardwood floor and went to ER but she was not admitted. They did x-rays and blood work but they said she was fine. The granddaughter took the phone and provided her grandmother received the first dose of the Pfizer COVID 19 vaccine on 27Feb2021 at 1535PM in the right arm. They are going at 1230 today to get then next dose. The patient has no history of all previous immunization with the COVID-19 Vaccine and has no additional vaccines administered on same date of the COVID-19 Vaccine. The event fall required emergency room visit but did not require hospital admission. The other event did not require physician office visit. The patient has no prior vaccinations within 4 weeks and has no medical history including any illness at time of vaccination. The patient has no family history.   No follow-up attempts are possible. No further information is expected.
severe chills and shivering  for 2 hours,  moderate chills for about 4 hours more. spiked a fever but don't know how high til 5 am when it was 102.5 and went down through the next day. Began vomiting  2 hours after onset. nausea and vomiting lasted intermittently for 24 hours Diarhea began that morning and lasted for 24 hours
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.  Processed by 27-MAY-2022.  On 14-Feb-2021 at 12:46 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 12:46 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The age of patient was provided as 48.96  Concomitant products were not provided.  On 14-Feb-2021, Excursion time was 9A, 10A, 11A, 2P, 3P temperature was 32, 32,32, 35,35 total doses given for the day was 162, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vials were sent to clinic. Vaccine BUD date was 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
TODAY DEVELOPED A RASH TO BOTH ARMS. WILL GIVE BENADRYL FOR RASH.  INFORMED POSSIBLY ALLERGIC TO VACCINE. DENIES ANY TROUBLE BREATHING OR SWALLOWING. SAW NURSE AT SCHOOL.
Approximately 2 hours after vaccinations were given, infant became apneic and unarousable.  The Infant required intubation.  Medical record on 04/30/04 states no new information.